Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
ALX-1 by Vast Therapeutics for Bronchiectasis: Likelihood of Approval
ALX-1 is under clinical development by Vast Therapeutics and currently in Phase I for Bronchiectasis. According to GlobalData, Phase I...